BDBM450801 US10676469, Compound 16::US11124504, Cpd. No. 16

SMILES Cc1noc(n1)-c1c(C)c2cc(cc(F)c2nc1N1CCC(CC1)N[C@H]1CCOC1)C1CCC1

InChI Key InChIKey=HXZSQLNGDLWNDY-FQEVSTJZSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 450801   

TargetMu-type opioid receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM450801(US10676469, Compound 16 | US11124504, Cpd. No. 16)
Affinity DataIC50: >1.00E+3nMAssay Description:The purpose of this assay is to confirm the potency and selectivity of compounds synthesized to be OPRK1 Antagonists. This assay monitors the OPRMu1 ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetKappa-type opioid receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM450801(US10676469, Compound 16 | US11124504, Cpd. No. 16)
Affinity DataIC50: >100nMAssay Description:The cell line for the OPRK1 antagonist assay stably expresses the following elements: The carboxy terminus of the OPRK1 receptor has a 7-amino acid l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent